港股異動 | 普拉達大漲超8% 市值有望重回千億港元
格隆匯10月17日丨普拉達(1913.HK)尾盤漲幅擴大至8.57%,報38港元,總市值970億港元,有望重回千億港元大關。管理層表示下半年可能受益於進一步的經營槓桿,並對中國市場的基本需求保持樂觀。10月11日,普拉達香水美粧正式登陸天貓。普拉達香水美粧電商總監黃毅書表示,我們非常看好中國市場,天貓作為最瞭解消費者的平台,非常期待即將到來的天貓雙11。據悉,下一步普拉達香水美粧店將上線更多美粧產品,全球首發新品也將率先登陸天貓。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.